TABLE 2.
Dose Level | Prexasertib Dose (mg/m2) | Part | No. of Patients Entered | No. of Patients Evaluable | No. of Patients with Cycle 1 DLTs | No. of Patients with Later-Cycle DLTs |
---|---|---|---|---|---|---|
1 | 80 | A | 6 | 6 | 0 | 0 |
2 | 100 | A | 6 | 5 | 0 | 0 |
3 | 125 | A | 6 | 4 | 0 | 0 |
4 | 150 | A | 6 | 5 | 0 | 0 |
4 | 150 | PK | 6 | 5 | 0 | 0 |
Abbreviations: A= dose-escalation cohort; DLT= dose-limiting toxicity; No.= number; PK= Pharmacokinetic expansion cohort